Oa. Al-swayeh et al., A comparison of the anti-inflammatory and anti-nociceptive activity of nitroaspirin and aspirin, BR J PHARM, 129(2), 2000, pp. 343-350
1 Nitroaspirin (2.5-50 mg kg(-1), i.p. or 2.5-100 mg kg(-1), p.o.) and aspi
rin (2.5-100 mg kg(-1) i.p. or p.o.) exhibit anti-inflammatory activity in
the carrageenan-induced hindpaw oedema model in the rat. When administered
i.p., nitroaspirin was a more effective anti-oedema agent than aspirin part
icularly in the 'early' phase (i.e. up to 60 min) of the response. The ED50
values for nitroaspirin and aspirin as inhibitors of the 'late' phase resp
onse (measured at 180 min) were 64.3 mu mol kg(-1) and >555 mu mol kg(-1),
respectively. When administered p.o., neither nitroaspirin nor aspirin exhi
bited significant anti-inflammatory activity in the 'early' phase and were
of similar potency in the 'late' phase. Thus, at the highest dose used (100
mg kg(-1), 360 min) orally administered nitroaspirin (aspirin in parenthes
is) inhibited oedema formation by 46.9 +/- 1.6% (47.2 +/- 3.8%, both n = 6,
P < 0.05).
2 Nitroaspirin and aspirin (25-200 mg kg(-1), p.o.) caused dose-related inh
ibition of the hyperalgesia to mechanical stimulation following intraplanta
r injection of carrageenan in the rat. ED50 values were 365 mu mol kg(-1) a
nd 784 mu mol kg(-1), respectively. Neither drug influenced the threshold f
or mechanical stimulation in the contralateral (i.e. untreated) hindpaw.
3 Nitroaspirin and aspirin (2.5-100 mg kg(-1), p.o.) caused dose-related in
hibition of acetic acid induced abdominal constrictions in the mouse (ED50
values of 154.7 mu mol kg(-1) and 242.8 mu mol kg(-1), respectively).
4 Nitroaspirin and aspirin (> 200 mg kg(-1), p.o.) reduced the 'late' phase
(but not the 'early' phase) of the formalin-induced hindpaw licking assay
in the mouse. Similarly, nitroaspirin and aspirin (> 50 mg kg(-1), p.o.) pr
olonged tail withdrawal latency following application of a noxious heat sti
mulus in the mouse.